Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Celgene Corporation and GlaxoSmithKline.

Clinical Interchange: Addressing Racial Disparities in Multiple Myeloma Care

Release Date: July 15, 2020
Expiration Date: July 15, 2021

Activity Overview

The Clinical Interchange™, one of PER’s signature educational formats, is a video-based program in which a panel of distinguished experts engage in discussions on a particular clinical topic. In this activity, 5 key thought leaders explore the latest data regarding the incidence of multiple myeloma (MM) among different racial populations and the racial disparities in myeloma care. The discussion also focuses on strategies for addressing these disparities. This lively discussion will help place new developments into clinical context to help you optimize care for your patients with multiple myeloma of different races and ethnicities.

Acknowledgement of Support

This activity is supported by educational grants from Celgene Corporation and GlaxoSmithKline.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.


Target Audience

This educational program is directed toward hematologist/oncologists and medical oncologists interested in the treatment of multiple myeloma. Nurse practitioners, physician assistants, nurses, and other health care professionals involved in the treatment and management of patients with multiple myeloma are invited to participate.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Recognize disease risk of MM in African American patients and barriers to optimized care
  • Review racial and ethnic differences in prevalence and biology of MM
  • Identify strategies to overcome racial and ethnic barriers to clinical trial participation and optimize outcomes for patients with MM
  • Outline clinical considerations with regard to disease presentation, treatment, and outcomes specific to African American patients with MM

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Chair

Craig Emmitt Cole, MD
Craig Emmitt Cole, MD
Assistant Professor of Medicine
Division of Hematology/Oncology
Director of Clinical Research-Breslin Cancer Center
Department of Medicine
College of Human Medicine
Breslin Cancer Center
Michigan State University
East Lansing, MI

Disclosures: Craig Emmitt Cole, MD has no relevant financial relationships with commercial interests.

Faculty

Sikander Ailawadhi, MD
Sikander Ailawadhi, MD
Professor of Medicine
Division of Hematology-Oncology
Mayo Clinic
Jacksonville, FL

Disclosures: Grant/Research Support: Pharmacyclics; Consultant: Takeda, Bristol Myers Squibb, Amgen, Janssen, Sanofi, BeiGene; Other Support: Research support to institution: Cellectar Biosciences, Amgen, AstraZeneca, Bristol Myers Squibb.

Irene Ghobrial, MD
Irene Ghobrial, MD
Professor of Medicine, Harvard Medical School
Director, Steven & Michele Kirsch Laboratory, DFCI
Co-Director, Center of Prevention for Progression (CPOP) Clinic, DFCI
Director, Clinical Investigator Research Program, DFCI
Senior Physician, DFCI
Senior Physician, BWH
Boston, MA

Disclosures: Consultant: GlaxoSmithKline, Sanofi, Janssen, Takeda, Celgene, Karyopharm, AbbVie, GNS Healthcare, Cellectar Biosciences, Medscape, Genentech/Roche, Adaptive Biotechnologies, Bristol Myers Squibb, Aptitude Medical Systems, Curio Biotech, Oncopeptides.

Shaji Kumar, MD
Shaji Kumar, MD
Professor of Medicine
Consultant, Division of Hematology, Division of Internal Medicine
Mayo Clinic
Rochester, MN

Disclosures: Grant/Research Support: Research funding for clinical trials to the institution: Celgene, Takeda, Janssen, Bristol Myer Squibb, Kite Pharma, Merck, AbbVie, MedImmune, Novartis, Genentech/Roche, Amgen, TeneoBio, CARsgen; Consultant: Consulting/Advisory Board participation: (with no personal payments) Celgene, Takeda, Janssen, AbbVie, Genentech/Roche, Amgen, Molecular Partners and (with personal payment) Oncopeptides, GeneCentrix, Cellectar Biosciences.

Nikhil Munshi, MD
Nikhil Munshi, MD
Professor, Medicine, Harvard Medical School
Kraft Family Chair
Director of Basic and Correlative Science, Jerome Lipper Multiple Myeloma Center
Professor of Medicine, Harvard Medical School
Boston VA Healthcare System
Boston, MA

Disclosures: Consultant: AbbVie, Adaptive, Amgen, BeiGene, Celgene, Janssen, Karyopharm, Takeda, OncoPep, Inc.; Other Support: OncoPep, Inc. (Ownership).

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
      1
2345678
9101112131415
16171819202122
23242526272829
3031
Filter By